Bellevue Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.36M | Sell |
|
|||||
|
2025
Q2 | $5.87M | Sell |
|
|||||
|
2025
Q1 | $11.2M | Sell |
|
|||||
|
2024
Q4 | $10.1M | Sell |
|
|||||
|
2024
Q3 | $33M | Sell |
|
|||||
|
2024
Q2 | $41.6M | Sell |
|
|||||
|
2024
Q1 | $54.7M | Buy |
|
|||||
|
2023
Q4 | $50.6M | Buy |
|
|||||
|
2023
Q3 | $44.1M | Buy |
|
|||||
|
2023
Q2 | $41.3M | Buy |
|
|||||
|
2023
Q1 | $27.2M | Buy |
|
|||||
|
2022
Q4 | $33.7M | Sell |
|
|||||
|
2022
Q3 | $22.2M | Sell |
|
|||||
|
2022
Q2 | $31.3M | Buy |
|
|||||
|
2022
Q1 | $29.8M | Buy |
|
|||||
|
2021
Q4 | $24.6M | Sell |
|
|||||
|
2021
Q3 | $24.8M | Buy |
|
|||||
|
2021
Q2 | $23.7M | Buy |
|